News & Events

Partners in FTD Care: Genetic FTD Trials Update – Approaching a Phase 3 Milestone

The FTD research landscape is on the verge of major developments. For the first time, a Phase 3 trial has been completed for a potentially disease-modifying treatment for genetic FTD,…

MORE

Comedian Shares Her FTD Caregiving Journey on Podcast

Obviously there’s nothing funny about an FTD diagnosis—even for someone who makes their living finding the humor in everyday life. But Kelsey Cook, a nationally touring comedian known for her…

MORE

People at Potential Risk of Developing FTD Share Views on Effects of Predictive Biomarker Testing

People at risk, or potentially at risk, of developing FTD from a genetic mutation shared their perspectives on the potential effects the results of predictive biomarker testing would have on…

MORE

Tips & Advice: The Hidden Economic Cost of an FTD Diagnosis

World FTD Awareness Week is highlighting the financial impact of FTD today. When families receive an FTD diagnosis, they face more than the emotional upheaval of a progressive neurological condition—they…

MORE

ALLFTD2 Study Receives Notice of Award for NIH Grant for Five Years of Funding

In exciting news for the FTD research community, the ALLFTD study has received funding from the National Institutes of Health for the next phase, currently referred to as ALLFTD2. ALLFTD…

MORE

Advocacy Update: FTD Research at NIH Highlighted in FY26 LHHS Appropriations Reports

AFTD is excited to share that congressional reports for the Fiscal Year (FY) 2026 Labor, Health and Human Services, Education, and Related Agencies (LHHS) appropriations bills in the Senate and…

MORE

AFTD Ambassador Carrie Edwards donates lottery winnings to AFTD

Carrie Edwards recently surprised Virginia lottery officials by telling them her plans for the $150,000 she won on September 8. Those plans? Give it all away. But those who know…

MORE

Group of MAPT Gene Variations Linked to Greater Risk of Pick’s Disease Pathology, Study Finds

A study published in The Lancet Neurology found that a MAPT genetic variant is associated with an increased risk of an FTD tau pathology called Pick’s disease. This MAPT gene…

MORE